drugset / Trial / NCT05072262
DSAEK/DMEK and Cystoid Macular Edema - the Role for Topical NSAIDs (Nepafenac) (DMEC)
RandomizedParallel-groupOpen-labelTreatment
Summary
The DMEC trial is a randomized clinical two-arm trial comparing inflammation and cystoid macular edema for the medication regimens postoperative topical NSAIDs and steroids to only postoperative topical steroids in patients undergoing corneal endothelial transplantations (DSAEK or DMEK).
Timeline
- Start
- 2022-11-25
- Primary completion
- 2024-06
- Completion
- 2026-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Nepafenac | Other / unclassified | 3 mg/ml | Topical |
| Background | Dexamethasone | Small molecule | 1 mg/ml | Topical |
Indications
No indication recorded.